During the last three months, 8 analysts shared their evaluations of Envista Holdings NVST, revealing diverse outlooks from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 2 | 4 | 2 | 0 | 0 |
Last 30D | 0 | 0 | 1 | 0 | 0 |
1M Ago | 0 | 0 | 0 | 0 | 0 |
2M Ago | 0 | 0 | 0 | 0 | 0 |
3M Ago | 2 | 4 | 1 | 0 | 0 |
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $33.25, a high estimate of $42.00, and a low estimate of $25.00. A 22.67% drop is evident in the current average compared to the previous average price target of $43.00.
Breaking Down Analyst Ratings: A Detailed Examination
An in-depth analysis of recent analyst actions unveils how financial experts perceive Envista Holdings. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
---|---|---|---|---|---|
Kevin Caliendo | UBS | Announces | Neutral | $26.00 | - |
Nathan Rich | Goldman Sachs | Lowers | Buy | $28.00 | $41.00 |
Tycho Peterson | JP Morgan | Lowers | Overweight | $32.00 | $42.00 |
Drew Ranieri | Morgan Stanley | Lowers | Overweight | $38.00 | $42.00 |
Jason Bednar | Piper Sandler | Lowers | Neutral | $25.00 | $39.00 |
Jonathan Bock | Stifel | Lowers | Buy | $36.00 | $45.00 |
Jason Bednar | Piper Sandler | Lowers | Overweight | $39.00 | $46.00 |
Drew Ranieri | Morgan Stanley | Lowers | Overweight | $42.00 | $46.00 |
Key Insights:
- Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Envista Holdings. This information provides a snapshot of how analysts perceive the current state of the company.
- Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Envista Holdings compared to the broader market.
- Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Envista Holdings's stock. This comparison reveals trends in analysts' expectations over time.
For valuable insights into Envista Holdings's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
Stay up to date on Envista Holdings analyst ratings.
About Envista Holdings
Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments comprising Specialty Products and Technologies and Equipment and Consumables. The Company's Specialty Products & Technologies segment develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. The Company's Equipment & Consumables segment manufactures dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems.
Financial Insights: Envista Holdings
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Growth: Envista Holdings's revenue growth over a period of 3 months has been noteworthy. As of 30 September, 2023, the company achieved a revenue growth rate of approximately 0.03%. This indicates a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Health Care sector.
Net Margin: Envista Holdings's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 3.41%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Envista Holdings's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 0.5%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Envista Holdings's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 0.32%, the company showcases efficient use of assets and strong financial health.
Debt Management: Envista Holdings's debt-to-equity ratio is below the industry average. With a ratio of 0.38, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
The Significance of Analyst Ratings Explained
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.